Fudan University Shanghai Cancer Center
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma | Biliary Tract Carcinoma | Recruiting | Phase 2 | 2026-01-14 | NCT05668884 | |
| Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC | Advanced Intrahepatic Cholangiocarcinoma | Not yet recruiting | Phase 2 | 2025-09-03 | NCT07152769 | |
| Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer | Disease Attributes, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm | Recruiting | Not applicable | 2025-05-06 | NCT06934018 | |
| HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence | Hepato Cellular Carcinoma (HCC) | Recruiting | Phase 2 | 2025-02-06 | NCT06812039 |